Review





Similar Products

93
Bio-Rad cmv gh biorad
Cmv Gh Biorad, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cmv gh biorad/product/Bio-Rad
Average 93 stars, based on 1 article reviews
cmv gh biorad - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Bio-Rad 2470 5437 mouse anti gb
2470 5437 Mouse Anti Gb, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2470 5437 mouse anti gb/product/Bio-Rad
Average 93 stars, based on 1 article reviews
2470 5437 mouse anti gb - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Biorbyt gh orb553478 biorbyt cambridge uk
Gh Orb553478 Biorbyt Cambridge Uk, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gh orb553478 biorbyt cambridge uk/product/Biorbyt
Average 93 stars, based on 1 article reviews
gh orb553478 biorbyt cambridge uk - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Thermo Fisher gh/gl-pe antibody
Gh/Gl Pe Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gh/gl-pe antibody/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
gh/gl-pe antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti gh antibody
Anti Gh Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gh antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti gh antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sc 58113 mouse anti cytomegalovirus ie1
Sc 58113 Mouse Anti Cytomegalovirus Ie1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sc 58113 mouse anti cytomegalovirus ie1/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
sc 58113 mouse anti cytomegalovirus ie1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech primary rabbit anti human gh polyclonal antibody
Primary Rabbit Anti Human Gh Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary rabbit anti human gh polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
primary rabbit anti human gh polyclonal antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ghs r1
Ghs R1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ghs r1/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
ghs r1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse anti gh monoclonal antibody
Mouse Anti Gh Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti gh monoclonal antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mouse anti gh monoclonal antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology monoclonal antibody against ebv gh/gl/gp42
A. Proportion of each group (PVS: n = 42, control: n = 22, pre-pandemic healthy control: n = 3448) seropositive for each of 31 common pathogen panels as determined by SERA, grouped by pathogen-type. Statistical significance determined by Fisher’s exact test corrected with FDR (Benjamini Hochberg). Star indicates panels for which pre-pandemic healthy controls were not analyzed. B. Heatmap showing supervised clustering of SERA-determined seropositivity to EBV, CMV, HSV-1, and HSV-2 across samples. Clusters were named for their herpesvirus dominance and are labeled accordingly. C. Herpes seropositivity composition for each cohort. Significance of relative enrichment for each cluster was calculated using Chi-square test of observed composition vs. expected composition. D, E Plasma reactivity to EBV <t>gp42</t> protein measured by ELISA shown by cohort, PVS and Control (D) and by groups Control-I, Control+I, PVS-I, and PVS+I (E) . F. SERA-derived z scores for the gp42 motif [VI]XLPHW among EBV-seropositive individuals only, plotted by cohort, n = 20 (Control), n = 38 (PVS) (F) and group, n = 11 (Control-I), n = 9 (Control+I), n = 12 (PVS-I), n = 26 (PVS+I) (G) . The dashed line represents the z -score threshold for epitope positivity defined by SERA. H. Three-dimensional mapping of the PVS-enriched linear peptide sequence [VI]XLPHW (purple) onto EBV gp42 (blue) in a complex with gH (light grey) and gL (dark grey) (PDB: 5T1D). I. Relationship between EBV gp42 [VI]XLPHW SERA z score and plasma concentration of anti-gp42 IgG. J. SERA-derived z scores for the gp350 motif KXRX[RQ]WXF among EBV-seropositive individuals only, plotted by cohort. The dashed line represents the z -score threshold for epitope positivity defined by SERA. K. The relationship between plasma concentration of IgG against EBV gp42 and the percentage of TNFα CD8+ T cells (of total CD8+ T cells). For all box plots, the central lines indicate the group median values, the top and bottom lines indicate the 75th and 25th percentiles, respectively, the whiskers represent 1.5× the interquartile range. Each dot represents one individual. Statistical significance of the difference in median values was determined using Kruskal–Wallis tests with Post hoc Dunn’s test and Bonferroni–Holm’s method to adjust for multiple comparisons. Correlation was assessed using Spearman’s correlation. The black line shows linear regression, and shading shows the 95% CIs.
Monoclonal Antibody Against Ebv Gh/Gl/Gp42, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody against ebv gh/gl/gp42/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
monoclonal antibody against ebv gh/gl/gp42 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A. Proportion of each group (PVS: n = 42, control: n = 22, pre-pandemic healthy control: n = 3448) seropositive for each of 31 common pathogen panels as determined by SERA, grouped by pathogen-type. Statistical significance determined by Fisher’s exact test corrected with FDR (Benjamini Hochberg). Star indicates panels for which pre-pandemic healthy controls were not analyzed. B. Heatmap showing supervised clustering of SERA-determined seropositivity to EBV, CMV, HSV-1, and HSV-2 across samples. Clusters were named for their herpesvirus dominance and are labeled accordingly. C. Herpes seropositivity composition for each cohort. Significance of relative enrichment for each cluster was calculated using Chi-square test of observed composition vs. expected composition. D, E Plasma reactivity to EBV gp42 protein measured by ELISA shown by cohort, PVS and Control (D) and by groups Control-I, Control+I, PVS-I, and PVS+I (E) . F. SERA-derived z scores for the gp42 motif [VI]XLPHW among EBV-seropositive individuals only, plotted by cohort, n = 20 (Control), n = 38 (PVS) (F) and group, n = 11 (Control-I), n = 9 (Control+I), n = 12 (PVS-I), n = 26 (PVS+I) (G) . The dashed line represents the z -score threshold for epitope positivity defined by SERA. H. Three-dimensional mapping of the PVS-enriched linear peptide sequence [VI]XLPHW (purple) onto EBV gp42 (blue) in a complex with gH (light grey) and gL (dark grey) (PDB: 5T1D). I. Relationship between EBV gp42 [VI]XLPHW SERA z score and plasma concentration of anti-gp42 IgG. J. SERA-derived z scores for the gp350 motif KXRX[RQ]WXF among EBV-seropositive individuals only, plotted by cohort. The dashed line represents the z -score threshold for epitope positivity defined by SERA. K. The relationship between plasma concentration of IgG against EBV gp42 and the percentage of TNFα CD8+ T cells (of total CD8+ T cells). For all box plots, the central lines indicate the group median values, the top and bottom lines indicate the 75th and 25th percentiles, respectively, the whiskers represent 1.5× the interquartile range. Each dot represents one individual. Statistical significance of the difference in median values was determined using Kruskal–Wallis tests with Post hoc Dunn’s test and Bonferroni–Holm’s method to adjust for multiple comparisons. Correlation was assessed using Spearman’s correlation. The black line shows linear regression, and shading shows the 95% CIs.

Journal: medRxiv

Article Title: Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination

doi: 10.1101/2025.02.18.25322379

Figure Lengend Snippet: A. Proportion of each group (PVS: n = 42, control: n = 22, pre-pandemic healthy control: n = 3448) seropositive for each of 31 common pathogen panels as determined by SERA, grouped by pathogen-type. Statistical significance determined by Fisher’s exact test corrected with FDR (Benjamini Hochberg). Star indicates panels for which pre-pandemic healthy controls were not analyzed. B. Heatmap showing supervised clustering of SERA-determined seropositivity to EBV, CMV, HSV-1, and HSV-2 across samples. Clusters were named for their herpesvirus dominance and are labeled accordingly. C. Herpes seropositivity composition for each cohort. Significance of relative enrichment for each cluster was calculated using Chi-square test of observed composition vs. expected composition. D, E Plasma reactivity to EBV gp42 protein measured by ELISA shown by cohort, PVS and Control (D) and by groups Control-I, Control+I, PVS-I, and PVS+I (E) . F. SERA-derived z scores for the gp42 motif [VI]XLPHW among EBV-seropositive individuals only, plotted by cohort, n = 20 (Control), n = 38 (PVS) (F) and group, n = 11 (Control-I), n = 9 (Control+I), n = 12 (PVS-I), n = 26 (PVS+I) (G) . The dashed line represents the z -score threshold for epitope positivity defined by SERA. H. Three-dimensional mapping of the PVS-enriched linear peptide sequence [VI]XLPHW (purple) onto EBV gp42 (blue) in a complex with gH (light grey) and gL (dark grey) (PDB: 5T1D). I. Relationship between EBV gp42 [VI]XLPHW SERA z score and plasma concentration of anti-gp42 IgG. J. SERA-derived z scores for the gp350 motif KXRX[RQ]WXF among EBV-seropositive individuals only, plotted by cohort. The dashed line represents the z -score threshold for epitope positivity defined by SERA. K. The relationship between plasma concentration of IgG against EBV gp42 and the percentage of TNFα CD8+ T cells (of total CD8+ T cells). For all box plots, the central lines indicate the group median values, the top and bottom lines indicate the 75th and 25th percentiles, respectively, the whiskers represent 1.5× the interquartile range. Each dot represents one individual. Statistical significance of the difference in median values was determined using Kruskal–Wallis tests with Post hoc Dunn’s test and Bonferroni–Holm’s method to adjust for multiple comparisons. Correlation was assessed using Spearman’s correlation. The black line shows linear regression, and shading shows the 95% CIs.

Article Snippet: Samples and a serial dilution curve of monoclonal antibody against EBV gH/gL/gp42 (MyBioSource #MBS430548) were diluted in 1% Omniblock non-fat dry milk in PBS and added to the plate to incubate for 1 hour at RT.

Techniques: Control, Labeling, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Derivative Assay, Sequencing, Concentration Assay